Inventor · disambiguated record
Michael Kornacker
Also filed as: KORNACKER MICHAEL · KORNACKER MICHAEL G · NEUBAUER MICHAEL G
24 granted patents·24 pending applications·132 citations·filing 1997–2024
96Inventor score
Top patents by PatentIndex Score
48 records- 0198US11230588B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 25, 2022·6 cites·29 claims
- 0298US11117949B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0398US11117950B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·28 claims
- 0498US11117948B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0598US11096988B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Aug 24, 2021·13 cites·19 claims
- 0697US11078282B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Aug 3, 2021·17 cites·33 claims
- 0795US11359022B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jun 14, 2022·2 cites·19 claims
- 0895US11319359B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2016·Granted May 3, 2022·9 cites·12 claims
- 0994US11639375B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted May 2, 2023·4 cites·28 claims
- 1094US11498967B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Nov 15, 2022·2 cites·24 claims
- 1194US11479609B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Oct 25, 2022·2 cites·18 claims
- 1294US10882914B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Jan 5, 2021·8 cites·45 claims
- 1391US11613566B2Variant ICOS ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Mar 28, 2023·1 cites·4 claims
- 1489US9605024B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 28, 2017·4 cites·16 claims
- 1582US2024409660A1Icos ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 1682US2024002466A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 1781US9303065B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 5, 2016·2 cites·4 claims
- 1881US8927688B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 6, 2015·2 cites·13 claims
- 1981US2023136723A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2078US11471488B2CD155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Oct 18, 2022·1 cites·22 claims
- 2177US11732022B2PD-L2 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Aug 22, 2023·1 cites·9 claims
- 2276US2023235012A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2375US7314726B2Beta secretase exosite binding peptides and methods for identifying beta secretase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 1, 2008·6 cites·3 claims
- 2474US12486312B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Dec 2, 2025·0 cites·25 claims
- 2573US11834490B2CD112 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Dec 5, 2023·1 cites·35 claims
- 2672US12110339B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2020·Granted Oct 8, 2024·0 cites·21 claims
- 2770US7713699B2Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23BRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 11, 2010·2 cites·4 claims
- 2861US2020283500A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 2961US2023381229A1Cd155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 3058US6051381AProkaryotic two-hybrid systemFiled 1997·Granted Apr 18, 2000·10 cites·24 claims
- 3155US2023220039A1Pd-l1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 3254US2004209808A1Modulators of human G-protein coupled receptorsFiled 2004·Application pending·0 cites
- 3349US2004214317A1Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brainBATTAGLINO PETER·Filed 2003·Application pending·0 cites
- 3447US2003198976A1Novel human G-protein coupled receptor, HGPRBMY14, related to the orphan GPCR, GPR73Filed 2002·Application pending·0 cites
- 3545US2003186265A1Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cordFiled 2002·Application pending·0 cites
- 3645US2004121330A1Novel human G-protein coupled receptor, HGPRBMY4, and methods of use thereofFiled 2002·Application pending·0 cites
- 3745US2003175748A1Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune- and colon- related tissuesFiled 2002·Application pending·0 cites
- 3845US2003170671A1Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestineFiled 2002·Application pending·0 cites
- 3944US2003100057A1Novel human G-protein coupled receptor, HGPRBMY14, related to the orphan GPCR, GPR73Filed 2002·Application pending·0 cites
- 4044US2003064438A1G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereofFiled 2002·Application pending·0 cites
- 4142US2007149763A1Beta secretase exosite binding peptides and methods for identifying beta secretase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 4242US2020040059A1Secretable variant immunomodulatory proteins and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2017·Application pending·0 cites
- 4340US2003186360A1Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune -and colon-related tissuesFiled 2001·Application pending·0 cites
- 4440US2003022183A1Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cordFiled 2001·Application pending·0 cites
- 4539US2018256644A1Tunable variant immunoglobulin superfamily domains and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2016·Application pending·0 cites
- 4639US2003054444A1Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brainFiled 2001·Application pending·0 cites
- 4738US2003044892A1Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestineFiled 2001·Application pending·0 cites
- 4834US2003022237A1Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lungFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →